Govt Job for Project Research Associate at RCB, Govt of India

Regional Centre for Biotechnology (RCB), an Institution of national importance established by the Department of Biotechnology, Govt. of India, with regional and global partnerships synergizing with the programmes of UNESCO.

The primary focus of RCB is to provide world class education, training and conduct innovative research at the interface of multiple disciplines to create high quality human resource in disciplinary and interdisciplinary areas of biotechnology in a globally competitive research milieu.

Post : Project Research Associate-I

Title of Project : ”Elucidation of the functional interactome of legumes with the fungal pathogen Erysiphe pisi as keys to powdery mildew disease resistance”. (The Project involves extensive protein purification, biochemical and biophysical characterization and structural studies).

Duration : Initially for one year, extendable on annual evaluation.
Age Limit : 37 Years

Essential Qualifications : PhD in Life Sciences. Minimum 60% marks in Masters or equivalent degree. Demonstrated experience (Substantiated by first author publication) in protein purification, crystallization and protein structure determination.

Desirable Qualifications : Experience in molecular biology techniques, biochemical and biophysical techniques, good oral and written communication skills and ability to work independently are preferred.

Fellowship :Rs. 47,000/- + 16% HRA per month.
Principal Investigator (PI) : Dr. Divya Chandran, Associate Professor; Co-PI: Dr. Deepti Jain, Associate Professor (The position will be in Dr. Deepti’s lab)

The shortlisted candidates will be informed by 20th March, 2021 via email to appear in the online interview to be held at 11:00 AM onwards on 22nd March, 2021. Candidates who applied previously to the same post in the same project, need not apply again.

Regional Centre for Biotechnology,
3rd Milestone, Faridabad-Gurgaon Expressway
NCR Biotech Science Cluster, Faridabad,
Faridabad (Haryana).

Related Posts

  • Pharma
  • July 16, 2025
  • 293 views
Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

Generic drugmakers Aurobindo Pharma, Cipla and Viatris will develop, manufacture and supply long-acting injectable cabotegravir (CAB LA) for HIV treatment in 133 countries. This follows ViiV Healthcare, a company focused…

  • Pharma
  • July 16, 2025
  • 95 views
Pharma stocks hover near flatline even as Trump hints at new tariffs by July-end

The pharma sector will be in focus on July 16, after Donald Trump said that pharmaceuticals tariffs would be implemented soon. Shares of pharmaceutical companies traded flat on Wednesday, July…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

Pharma stocks hover near flatline even as Trump hints at new tariffs by July-end

Pharma stocks hover near flatline even as Trump hints at new tariffs by July-end

Govt revises prices of 71 medicines, including those for diabetes and infections: Check new rates

Govt revises prices of 71 medicines, including those for diabetes and infections: Check new rates